SecSonar.com

Scilex Holding Company (SCLX)

Scilex Holding Company at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Scilex Holding Company (SCLX) is a Drug Manufacturers - General company based in US with a market capitalization of $79M. Revenue declined 46.5% year-over-year and the company generated $3.7M in free cash flow. This page tracks SCLX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 115 employees · IPO Mar 5, 2021

Valuation

Valuation & price

$6.11 · as of May 23, 2026 · -79.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$30.00$16.86$3.72Jul 25Dec 25Jul 26Jul 7, 25$6.25Jul 9, 25$6.40Jul 11, 25$6.46Jul 15, 25$6.73Jul 17, 25$9.25Jul 21, 25$8.60Jul 23, 25$11.36Jul 25, 25$11.96Jul 29, 25$15.95Jul 31, 25$13.42Aug 4, 25$14.96Aug 6, 25$14.91Aug 11, 25$15.82Aug 13, 25$21.00Aug 15, 25$18.08Aug 19, 25$17.96Aug 21, 25$17.14Aug 25, 25$18.29Aug 27, 25$18.02Aug 29, 25$17.76Sep 3, 25$18.86Sep 5, 25$22.80Sep 9, 25$25.13Sep 11, 25$25.36Sep 16, 25$22.56Sep 18, 25$25.66Sep 22, 25$30.00Sep 24, 25$28.59Sep 26, 25$29.21Sep 30, 25$19.68Oct 2, 25$17.35Oct 6, 25$16.82Oct 8, 25$17.58Oct 10, 25$14.93Oct 14, 25$14.58Oct 16, 25$13.31Oct 21, 25$13.75Oct 23, 25$14.59Oct 27, 25$18.99Oct 29, 25$18.44Oct 31, 25$16.50Nov 4, 25$19.72Nov 6, 25$16.95Nov 10, 25$18.35Nov 12, 25$18.92Nov 14, 25$17.69Nov 18, 25$16.37Nov 20, 25$18.95Nov 25, 25$20.25Nov 28, 25$20.36Dec 2, 25$18.75Dec 4, 25$19.40Dec 8, 25$17.93Dec 10, 25$17.29Dec 12, 25$16.63Dec 16, 25$15.76Dec 18, 25$14.61Dec 22, 25$14.27Dec 24, 25$13.82Dec 29, 25$13.68Jan 2, 26$13.09Jan 6, 26$13.10Jan 8, 26$13.29Jan 12, 26$13.40Jan 14, 26$12.00Jan 16, 26$11.34Jan 21, 26$10.60Jan 23, 26$10.99Jan 27, 26$9.44Jan 29, 26$8.69Feb 2, 26$9.14Feb 4, 26$8.75Feb 9, 26$8.61Feb 11, 26$8.56Feb 13, 26$8.31Feb 18, 26$8.22Feb 20, 26$8.12Feb 24, 26$8.16Feb 26, 26$8.12Mar 2, 26$8.09Mar 4, 26$8.73Mar 6, 26$8.48Mar 10, 26$8.65Mar 12, 26$8.81Mar 17, 26$8.15Mar 19, 26$7.80Mar 23, 26$7.35Mar 25, 26$6.72Mar 27, 26$6.41Mar 31, 26$6.66Apr 2, 26$7.44Apr 7, 26$7.02Apr 9, 26$7.01Apr 13, 26$5.96Apr 15, 26$6.30Apr 17, 26$6.90Apr 22, 26$7.24Apr 24, 26$6.69Apr 28, 26$6.90Apr 30, 26$10.52May 4, 26$11.15May 6, 26$9.50May 8, 26$7.82May 12, 26$6.81May 14, 26$6.50May 18, 26$3.72May 20, 26$3.74May 22, 26$3.80May 28, 26$4.49Jun 1, 26$4.97Jun 3, 26$4.46Jun 5, 26$4.36Jun 9, 26$4.38Jun 11, 26$5.42Jun 15, 26$4.95Jun 17, 26$6.94Jun 22, 26$6.87Jun 24, 26$6.86Jun 26, 26$7.11Jul 2, 26$7.81
$3.6952-week range$30.00
Loading valuation history…

Fundamentals

Key fundamentals

$79M

Market cap

-46.5%

Revenue growth (YoY)

49.7%

Gross margin

$3.7M

Free cash flow (USD)

$121.6M

Net debt

58.7%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$21.0MFY 2020$23.6MFY 2021$31.3MFY 2022$38.0MFY 2023$46.7MFY 2024$56.6MFY 2025$30.3M
$21M$30.3M

Free cash flow by year

2019 → 2025

FY 2019$-61.0MFY 2020$-31.5MFY 2021$-28.7MFY 2022$-23.3MFY 2023$-21.0MFY 2024$19.3MFY 2025$3.7M
-$61M$3.7M

Gross margin by year

2021 → 2025

FY 202188.4%FY 202271.6%FY 202366.5%FY 202470.5%FY 202549.7%
88.4%49.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 20, 2026 (EPS $-4.76)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBitcoin Purchase AgreementJun 29, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 24, 2026Filing
  • FinancingSecurities RegistrationJun 2, 2026Filing
  • Quarterly report10-Q FiledMay 20, 2026Filing
  • 8-K eventDividend DeclaredMay 11, 2026Filing
  • 8-K eventStock Acquisition AgreementMay 5, 2026Filing
  • 8-K eventCash Contribution AgreementApr 28, 2026Filing
  • FinancingSecurities RegistrationApr 16, 2026Filing
  • Annual report10-K FiledApr 10, 2026Filing

Questions

Frequently asked questions

What is Scilex Holding Company's market cap?

Scilex Holding Company (SCLX) has a market capitalization of $79M.

What is SCLX's P/E ratio?

A meaningful P/E ratio is not available for SCLX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did Scilex Holding Company last report earnings?

SCLX last reported earnings on May 20, 2026; the next date is not yet scheduled.

Are insiders buying SCLX stock?

SEC Form 4 filings show no open-market insider buys at Scilex Holding Company in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - General

SRXH

SRx Health Solutions Inc.

$3.9M

OGN

Organon & Co.

$3.5B

GRFS

Grifols, S.A.

$6.7B

BIIB

Biogen Inc.

$29.2B

ZTS

Zoetis Inc.

$32.6B

GSK

GSK plc

$101.9B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.